DEC 06, 2017 05:47 PM PST

New Breast Cancer Vaccine Shows Promise in Mice

WRITTEN BY: Carmen Leitch

In recent years there has been an intense focus on the development of vaccines for breast cancer. The strategy employed is to get the immune system to see cancer cells as foreign invaders that have to be destroyed; they use the natural defense systems of the human body to battle cancer. Researchers at the University of Copenhagen and the University of Bologna have now developed a vaccine for what is commonly called HER2-positive breast cancer, which causes around 25 percent of cases. Testing performed in a mouse model shows promise and has been reported in OncoImmunology.

To get the immune system to identify cancer cells as foreign, the scientists added a molecule called an antigen, normally found on the surface of cancer cells, to a virus-like particle. Typically, the immune system has a hard time telling the difference between healthy and cancerous cells. The added antigen acts to provoke a robust immune response to cancer.

“Our virus-like particle with the added cancer antigen makes the body believe it is under attack. This makes the immune system produce large amounts of antibodies targeted at the cancer antigen, which then fights the cancer cells in the mice,” explained study author Adam F. Sander, an Associate Professor from the Department of Immunology and Microbiology.

The vaccine was shown to not only have a preventive effect, but it can also have an impact on cancer that already developed. Two different mouse groups illustrated this. 

Mice genetically engineered to develop two kinds of breast cancer spontaneously were exposed to the vaccine. One group developed cancer, but the tumors were significantly smaller than usual, and there were fewer of them. In the other group, vaccinated mice did not get cancer at all. This showed that depending on the genetic variant carried by the mice, the vaccine stopped breast cancer before it started in 50 to 100 percent of cases.

Other tests used mice that already carried cancer at the time of treatment with the vaccine. These mice carried tumor fragments or with human cancer cells. The vaccine cured 80 percent of the mice with tumor fragments. The mice that received human cancer cells and the vaccine did get cancer, but it developed far more slowly than usual.

Mouse models aided this research / Image derived from Wikimedia Commons

In another set of experiments, blood was taken from mice that had produced antibodies because of the vaccine. That blood was put on human cancer cells; the researchers found that the antibodies bound to these human cancer cells.

HER2-positive breast cancer is currently treated using a lot of antibodies that battle it, which takes a long time. This is an expensive treatment which has serious side effects. The immune system can also build up a tolerance to the antibodies over time, making them ineffective. The researchers think that their new vaccine will be much more affordable if they can recapitulate its effects in humans.

“What is exciting about our treatment technique is that it makes the body do the work. We do not inject foreign antibodies, but leave it to the body to produce them,” said study author Susan Thrane, a postdoctoral fellow.

The researchers are hopeful that soon, human trials to test this vaccine will happen.

 

Sources: AAAS/Eurekalert! Via University of Copenhagen, Oncology Journal, OncoImmunology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
A More Precise Version of CRISPR/Cas9 is Created
A more accurate version of Cas9 has been created, reducing the number of off-target effects. It may be better suited for use in gene therapy....
DEC 06, 2019
Cell & Molecular Biology
DEC 06, 2019
Improving the Ways Scientists Model Organs and Disease
Organoids - miniature, simplified versions of organs made from stem cells, are a great way to model human biology and disease....
DEC 06, 2019
Drug Discovery & Development
DEC 06, 2019
Gene Variant Could Be a Therapeutic Target For Alzheimer Disease
A variation in genetics for an individual at high-risk for Alzheimer development has defied the odds for being dementia-free way beyond anticipated. The in...
DEC 06, 2019
Clinical & Molecular DX
DEC 06, 2019
New diagnostic technology seeks out cancer DNA in blood
For many cancers, early detection has a tremendous impact on patient outcomes. Yet, sadly, many of the most common malignancies, like those of the stomach,...
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Evaluating the Genetic Damage Caused by Cancer Treatments
Now that we know more about the impact of some cancer treatments, they can be applied optimally....
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
The Gene Behind Friendly Human Faces
Domesticated dogs have differet facial features to their wild cousins, wolves, with smaller teeth, floppy ears and shorter faces. And humans are no differe...
Loading Comments...